Personalized and Precision Medicine International Conference – PEMED 2021

The right therapeutic/prevention strategy for the right person at the right time.

Whether you are interested in diagnostics, bioinformatics, drug discovery, and therapies, with the aim of translating precision medicine into direct improvements in health care, PEMED is the place to be. This annual Personalized and Precision Medicine International Conference gathers the best experts in the field to meet, discuss and eventually do business.

 

A Virtual Edition

Please note that the committee has experience with organizing interactive online conferences. We have designed an intuitive dashboard representing the conference lobby and where you can access to each room with a single click. A welcome desk will be available every day with a staff member that you can talk with and each participant can ask for a technical test prior to the event by sending an email to pemed2021@premc.org. You will have access to the participant’s list before the conference via a networking app and several activities will be available during the breaks to facilitate the networking between participants, there will be also rooms dedicated to the speakers in order to extend the Q&A and others dedicated to open positions opportunities to encourage the creation of new collaborations. All live speakers will be contacted by the committee at least one week before the conference in order to run a quick technical test.

This format will allow us to maintain the link within the community during these uncertain times. Moreover, this conference will be eco-friendly and cheaper.

How to access the conference rooms?

An intuitive conference dashboard has been designed to provide you with quick and easy access to all conference rooms.

A welcome desk will be available every day with a staff member that you can talk with and each participant can ask for a technical test prior to the event by sending an email to pemed2021@premc.org.



  • TOPICS
  • Personalized therapies (cancer, immunology, infectious diseases, clinical case studies, etc.)
  • Biomarkers and diagnostics, liquid biopsy, imaging, biochip/microarray technologies, advancements in technologies
  • Drug target discovery and integration with individualized therapy, integration of diagnosis with therapy (theragnosis)
  • Integrating Big Data (genome data, pharmacogenomics, therapeutic applications of genome editing, genetic analysis in clinical trials methodology, etc.)
  • Emerging opportunities in personalized medicine, cutting-edge new strategies and solutions
  • Cost-benefit issues, and ethics in precision medicine

You can still register here:

CHAIRMAN

Prof. Manel Esteller

Prof. Manel Esteller

Director of Josep Carreras Leukaemia Research Institute (IJC), Spain

STEERING COMMITTEE 

Prof. Ann K. Daly

Prof. Ann K. Daly

University Medical School, United Kingdom

Prof. Matthias Schwab

Prof. Matthias Schwab

IKP and Dept of Clinical Pharmacology, Univ Hospital of Tuebingen, Germany

Prof. Anne-Marie Caminade

Prof. Anne-Marie Caminade

Coordination Chemistry Lab of Toulouse and University of Toulouse, France

PLENARY SPEAKERS

Prof. Alberto Bardelli

Prof. Alberto Bardelli

University of Torino, Italy

Prof. Paul Bastard

Prof. Paul Bastard

Laboratory of Human Genetics of Infectious diseases, Imagine Institue (France) and The Rockefeller University (United States)

 Prof. Julià Blanco

Prof. Julià Blanco

Senior Researcher IGTP/IrsiCaixa, Associate Professor UVIC-UCC, Spain

Prof. Anne-Marie Caminade

Prof. Anne-Marie Caminade

Coordination Chemistry Lab of Toulouse and University of Toulouse, France

Prof. Emmanouil Dermitzakis

Prof. Emmanouil Dermitzakis

Coming soon

Dr. Olivier Elemento

Dr. Olivier Elemento

Director of the Caryl and Israel Englander Institute for Precision Medicine, United States

Prof. Manel Esteller

Prof. Manel Esteller

Josep Carreras Leukaemia Research Institute (IJC), Spain

Prof. Mingzhou Guo

Prof. Mingzhou Guo

Department of Gastroenterology & Hepatology, Chinese PLA General Hospital, Beijing China

Prof. Åslaug Helland

Prof. Åslaug Helland

Oslo University Hospital and University of Oslo, Norway

Prof. Maria Jose Alonso

Prof. Maria Jose Alonso

CIMUS Research Institute, Faculty of Pharmacy, University of Santiago de Compostela, Spain

Prof. Ann K. Daly

Prof. Ann K. Daly

Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom

Prof. Ari M. Melnick

Prof. Ari M. Melnick

Gebroe Family Professor of Hematology/Oncology, United States

Prof. Stefan M Pfister

Prof. Stefan M Pfister

Coming soon

Dr. Eduard Porta

Dr. Eduard Porta

Josep Carreras Leukemia Research Institute Barcelona Supercomputing Center (BSC), Spain

Prof. Hege Russnes

Prof. Hege Russnes

Coming soon

Prof. Julio Saez-Rodriguez

Prof. Julio Saez-Rodriguez

Coming soon

Dr. Montse Sanchez-Cespedes

Dr. Montse Sanchez-Cespedes

Cancer Genetics Group, United Kingdom

 Prof. Matthias Schwab

Prof. Matthias Schwab

IKP and Dept of Clinical Pharmacology, Univ Hospital of Tuebingen, Germany

Dr. Elaine S. Jaffe

Dr. Elaine S. Jaffe

National Cancer Institute, United States

Prof. Kari Stefansson

Prof. Kari Stefansson

CEO and founder of deCODE genetics, Iceland

Prof. Amos Tanay

Prof. Amos Tanay

Weizmann Institute, Israel

Prof. Qian Zhang

Prof. Qian Zhang

Rockefeller University, New York City, United States

HIGHLIGHT OF THE PREVIOUS EDITION

PEMED 2020 in Munich
annic 2017 rome